Selinexor Combined With R-GemOx as Second-line Treatment in Patients With Diffuse Large B-cell Lymphoma
Clinical trial NCT05786989 · UNKNOWN
Trial details
- NCT number
- NCT05786989
- Sponsor
- Chongqing University Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-28
- Primary completion
- 2024-03-31
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.